Literature DB >> 7128719

Leishmania tropica: surface antigens of intracellular and flagellate forms.

E Handman, J M Curtis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128719     DOI: 10.1016/0014-4894(82)90133-3

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  8 in total

1.  Solubilization and partial purification of a cell surface component of Leishmania braziliensis.

Authors:  J A Misle; M E Márquez; A G Hernández
Journal:  Z Parasitenkd       Date:  1985

2.  Identification of cytoplasmic soluble antigens related to the major surface antigens of Leishmania braziliensis braziliensis and L. donovani chagasi.

Authors:  S Kutner; P Pellerin; S F Breniere
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Identification and characterization of a major surface antigen of Giardia lamblia.

Authors:  D A Einfeld; H H Stibbs
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Identification of cross-reactive promastigote cell surface antigens of some leishmanial stocks by 125I labeling and immunoprecipitation.

Authors:  P R Gardiner; C L Jaffe; D M Dwyer
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Differences in expression and exposure of promastigote and amastigote membrane molecules in Leishmania tropica.

Authors:  M D Sadick; H V Raff
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

6.  Amastigote stage-specific monoclonal antibodies against Leishmania major.

Authors:  C L Jaffe; N Rachamim
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

7.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18

8.  A common major surface antigen on amastigotes and promastigotes of Leishmania species.

Authors:  V Colomer-Gould; L Glvao Quintao; J Keithly; N Nogueira
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.